📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Clinical Advances of Hypoxia-Activated Prodrugs in Combination With Radiation Therapy. (2017)

First Author: Mistry IN

Attributed to: Chemical bioreductive approaches to targeted radiosensitisation and imaging of tumours funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ijrobp.2017.03.024

PubMed Identifier: 28721903

Publication URI: http://europepmc.org/abstract/MED/28721903

Type: Journal Article/Review

Volume: 98

Parent Publication: International journal of radiation oncology, biology, physics

Issue: 5

ISSN: 0360-3016